HealthLeaders Media April 16, 2019
When policymakers say they aim to eliminate the middlemen who drive up healthcare costs, they’re not just talking about prescription drugs.
KEY TAKEAWAYS
The White House has had some strong words for PBMs in the past year, backed by consequential policy proposals.
There’s also talk of policy action that could undercut middlemen in the relationship between payers and providers.
Skeptics say there’s likely not enough political consensus to take every drastic steps under consideration. But what if they’re wrong?
Pharmacy benefit managers took their turn in the spotlight last week, sending executives to Capitol Hill to testify that drugmakers are largely to blame for ever-rising drug prices.
The PBMs have been under increasing pressure...
Today's Sponsors
Today's Sponsor